Shared and separate functions of the RAMP-based adrenomedullin receptors

Peptides

Volumn 32, Issue 7, 2011, Pages 1540-1550

  Kuwasako, Kenji ^a   Kitamura, Kazuo ^b   Nagata, Sayaka ^b   Hikosaka, Tomomi ^b   Takei, Yoshio ^c   Kato, Johji ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Adrenomedullin; Adrenomedullin 2; Calcitonin receptor like receptor; Cardiovascular diseases; Genetically engineered mouse; Receptor activity modifying protein

Indexed keywords

ADRENOMEDULLIN RECEPTOR; ANGIOTENSIN II; BETA ARRESTIN; CALCITONIN RECEPTOR LIKE RECEPTOR; G PROTEIN COUPLED RECEPTOR KINASE; INTERMEDIN; RECEPTOR ACTIVITY MODIFYING PROTEIN 2; RECEPTOR ACTIVITY MODIFYING PROTEIN 3;

ALPHA HELIX; BINDING AFFINITY; BODY WEIGHT; CARDIOVASCULAR SYSTEM; CRYSTAL STRUCTURE; FETUS DEVELOPMENT; GENE EXPRESSION; HEMODYNAMIC STRESS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; TRANSGENIC MOUSE; VASCULAR DISEASE;

ADRENOMEDULLIN; AGING; AMINO ACID SEQUENCE; ANIMALS; BODY WEIGHT; CALCITONIN GENE-RELATED PEPTIDE; CALCITONIN RECEPTOR-LIKE PROTEIN; CARDIOVASCULAR DISEASES; CELL LINE; GENE EXPRESSION; HUMANS; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; PROTEIN TRANSPORT; RATS; RATS, TRANSGENIC; RECEPTOR ACTIVITY-MODIFYING PROTEIN 2; RECEPTOR ACTIVITY-MODIFYING PROTEIN 3; RECEPTORS, ADRENOMEDULLIN; RECEPTORS, CALCITONIN; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION;

EID: 79960291828     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2011.05.022     Document Type: Review

References (145)

1. N. Aiyar, J. Disa, Z. Ao, D. Xu, A. Surya, and K. Pillarisetti Molecular cloning and pharmacological characterization of bovine calcitonin receptor-like receptor from bovine aortic endothelial cells Biochem Pharmacol 63 2002 1949 1959
2. N. Aiyar, J. Disa, M. Pullen, and P. Nambi Receptor activity modifying proteins interaction with human and porcine calcitonin receptor-like receptor (CRLR) in HEK-293 cells Mol Cell Biochem 224 2001 123 133 (Pubitemid 32962658)
3. N. Aiyar, K. Rand, N.A. Elshourbagy, Z. Zeng, J.E. Adamou, and D.J. Bergsma A cDNA encoding the calcitonin gene-related peptide type 1 receptor J Biol Chem 271 1996 11325 11329 (Pubitemid 26155969)
4. S.G. Amara, V. Jonas, M.G. Rosenfeld, E.S. Ong, and R.M. Evans Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products Nature 298 1982 240 244 (Pubitemid 12089405)
5. R.J. Bailey, and D.L. Hay Agonist-dependent consequences of proline to alanine substitution in the transmembrane helices of the calcitonin receptor Br J Pharmacol 151 2007 678 687 (Pubitemid 47016286)
6. S. Banerjee, J. Evanson, E. Harris, S.L. Lowe, K.A. Thomasson, and J.E. Porter Identification of specific calcitonin-like receptor residues important for calcitonin gene-related peptide high affinity binding BMC Pharmacol 6 2006 9
7. J. Barwell, P.S. Miller, D. Donnelly, and D.R. Poyner Mapping interaction sites within the N-terminus of the calcitonin gene-related peptide receptor; the role of residues 23-60 of the calcitonin receptor-like receptor Peptides 31 2010 170 176
8. D. Bell, and B.J. McDermott Intermedin (adrenomedullin-2): a novel counter-regulatory peptide in the cardiovascular and renal systems Br J Pharmacol 153 Suppl. 1 2008 S247 S262
9. D. Bell, Y. Zhao, F.P. McCoy, A. Devine, and B.J. McDermott Expression of the counter-regulatory peptide intermedin is augmented in the presence of oxidative stress in hypertrophied cardiomyocytes Cell Physiol Biochem 21 2008 409 420 (Pubitemid 351620294)
10. D. Bell, Y. Zhao, F.P. McCoy, A.B. Devine, and B.J. McDermott Differential effects of an anti-oxidant intervention on cardiomyocyte expression of adrenomedullin and intermedin and their receptor components in chronic nitric oxide deficiency Cell Physiol Biochem 20 2007 269 282 (Pubitemid 47340590)
11. D. Bell, Y.Y. Zhao, A.B. Devine, and B.J. McDermott Influence of atenolol and nifedipine on nitric-oxide deficient cardiomyocyte hypertrophy and expression of the cardio-endocrine peptide intermedin and its receptor components Cell Physiol Biochem 21 2008 203 214
12. D. Bell, Y.Y. Zhao, E.J. Kelso, E.M. McHenry, L.M. Rush, and V.M. Lamont Upregulation of adrenomedullin and its receptor components during cardiomyocyte hypertrophy induced by chronic inhibition of nitric oxide synthesis in rats Am J Physiol Heart Circ Physiol 290 2006 H904 H914
13. J. Beltowski, and A. Jamroz Adrenomedullin - what do we know 10 years since its discovery? Pol J Pharmacol 56 2004 5 27 (Pubitemid 38515282)
14. I. Bernatova, O. Pechanova, and F. Simko Effect of captopril in L-NAME-induced hypertension on the rat myocardium, aorta, brain and kidney Exp Physiol 84 1999 1095 1105
15. J.M. Bomberger, N. Parameswaran, C.S. Hall, N. Aiyar, and W.S. Spielman Novel function for receptor activity-modifying proteins (RAMPs) in post-endocytic receptor trafficking J Biol Chem 280 2005 9297 9307 (Pubitemid 40409622)
16. J.M. Bomberger, W.S. Spielman, C.S. Hall, E.J. Weinman, and N. Parameswaran Receptor activity-modifying protein (RAMP) isoform-specific regulation of adrenomedullin receptor trafficking by NHERF-1 J Biol Chem 280 2005 23926 23935 (Pubitemid 40884881)
17. Y.N. Cao, K. Kitamura, J. Kato, K. Kuwasako, K. Ito, and H. Onitsuka Chronic salt loading upregulates expression of adrenomedullin and its receptors in adrenal glands and kidneys of the rat Hypertension 42 2003 369 372 (Pubitemid 37093487)
18. K.M. Caron, and O. Smithies Extreme hydrops fetalis and cardiovascular abnormalities in mice lacking a functional Adrenomedullin gene Proc Natl Acad Sci U S A 98 2001 615 619 (Pubitemid 32105091)
19. C.L. Chang, J. Roh, and S.Y. Hsu Intermedin, a novel calcitonin family peptide that exists in teleosts as well as in mammals: a comparison with other calcitonin/intermedin family peptides in vertebrates Peptides 25 2004 1633 1642 (Pubitemid 39346205)
20. J. Chao, L. Jin, K.F. Lin, and L. Chao Adrenomedullin gene delivery reduces blood pressure in spontaneously hypertensive rats Hypertens Res 20 1997 269 277
21. M. Chauhan, K. Rajarathnam, and C. Yallampalli Role of the N-terminal domain of the calcitonin receptor-like receptor in ligand binding Biochemistry 44 2005 782 789 (Pubitemid 40105510)
22. L. Chen, B. Kis, H. Hashimoto, D.W. Busija, Y. Takei, and H. Yamashita Adrenomedullin 2 protects rat cerebral endothelial cells from oxidative damage in vitro Brain Res 1086 2006 42 49
23. T. Chiba, A. Yamaguchi, T. Yamatani, A. Nakamura, T. Morishita, and T. Inui Calcitonin gene-related peptide receptor antagonist human CGRP-(8-37) Am J Physiol 256 1989 E331 E335
24. T. Choksi, D.L. Hay, S. Legon, D.R. Poyner, S. Hagner, and S.R. Bloom Comparison of the expression of calcitonin receptor-like receptor (CRLR) and receptor activity modifying proteins (RAMPs) with CGRP and adrenomedullin binding in cell lines Br J Pharmacol 136 2002 784 792 (Pubitemid 34785721)
25. A.C. Conner, D.L. Hay, S.G. Howitt, K. Kilk, U. Langel, and M. Wheatley Interaction of calcitonin-gene-related peptide with its receptors Biochem Soc Trans 30 2002 451 455 (Pubitemid 35001575)
26. R. Dackor, K. Fritz-Six, O. Smithies, and K. Caron Receptor activity-modifying proteins 2 and 3 have distinct physiological functions from embryogenesis to old age J Biol Chem 282 2007 18094 18099 (Pubitemid 47100252)
27. R.T. Dackor, K. Fritz-Six, W.P. Dunworth, C.L. Gibbons, O. Smithies, and K.M. Caron Hydrops fetalis, cardiovascular defects, and embryonic lethality in mice lacking the calcitonin receptor-like receptor gene Mol Cell Biol 26 2006 2511 2518
28. J.L. Deville, S. Salas, D. Figarella-Branger, L. Ouafik, and L. Daniel Adrenomedullin as a therapeutic target in angiogenesis Expert Opin Ther Targets 14 2010 1059 1072
29. L. Dewachter, C. Dewachter, and R. Naeije New therapies for pulmonary arterial hypertension: an update on current bench to bedside translation Expert Opin Investigational Drugs 19 2010 469 488
30. E. Dobrzynski, D. Montanari, J. Agata, J. Zhu, J. Chao, and L. Chao Adrenomedullin improves cardiac function and prevents renal damage in streptozotocin-induced diabetic rats Am J Physiol Endocrinol Metab 283 2002 E1291 E1298
31. S. Eguchi, Y. Hirata, H. Iwasaki, K. Sato, T.X. Watanabe, and T. Inui Structure-activity relationship of adrenomedullin, a novel vasodilatory peptide, in cultured rat vascular smooth muscle cells Endocrinology 135 1994 2454 2458 (Pubitemid 24377402)
32. S. Eguchi, Y. Hirata, H. Kano, K. Sato, Y. Watanabe, and T.X. Watanabe Specific receptors for adrenomedullin in cultured rat vascular smooth muscle cells FEBS Lett. 340 1994 226 230 (Pubitemid 24080955)
33. T. Eto A review of the biological properties and clinical implications of adrenomedullin and proadrenomedullin N-terminal 20 peptide (PAMP), hypotensive and vasodilating peptides Peptides 22 2001 1693 1711 (Pubitemid 34062786)
34. S.S. Ferguson Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling Pharmacol Rev 53 2001 1 24 (Pubitemid 32173106)
35. T.J. Fitzsimmons, X. Zhao, and S.A. Wank The extracellular domain of receptor activity-modifying protein 1 is sufficient for calcitonin receptor-like receptor function J Biol Chem 278 2003 14313 14320 (Pubitemid 36799981)
36. N.J. Fraser, A. Wise, J. Brown, L.M. McLatchie, M.J. Main, and S.M. Foord The amino terminus of receptor activity modifying proteins is a critical determinant of glycosylation state and ligand binding of calcitonin receptor-like receptor Mol Pharmacol 55 1999 1054 1059 (Pubitemid 29252372)
37. K.L. Fritz-Six, W.P. Dunworth, M. Li, and K.M. Caron Adrenomedullin signaling is necessary for murine lymphatic vascular development J Clin Invest 118 2008 40 50
38. Y. Fujisawa, Y. Nagai, A. Miyatake, Y. Takei, K. Miura, and T. Shoukouji Renal effects of a new member of adrenomedullin family, adrenomedullin2, in rats Eur J Pharmacol 497 2004 75 80 (Pubitemid 39099215)
39. C. Gibbons, R. Dackor, W. Dunworth, K. Fritz-Six, and K.M. Caron Receptor activity-modifying proteins: RAMPing up adrenomedullin signaling Mol Endocrinol 21 2007 783 796 (Pubitemid 46984723)
40. S. Hagner, U. Stahl, B. Knoblauch, G.P. McGregor, and R.E. Lang Calcitonin receptor-like receptor: identification and distribution in human peripheral tissues Cell Tissue Res 310 2002 41 50
41. P. Hasbak, A. Sams, S. Schifter, J. Longmore, and L. Edvinsson CGRP receptors mediating CGRP-, adrenomedullin- and amylin-induced relaxation in porcine coronary arteries. Characterization with 'Compound 1' (WO98/11128), a non-peptide antagonist Br J Pharmacol 133 2001 1405 1413 (Pubitemid 32783503)
42. D.L. Hay, G. Christopoulos, A. Christopoulos, D.R. Poyner, and P.M. Sexton Pharmacological discrimination of calcitonin receptor: receptor activity-modifying protein complexes Mol Pharmacol 67 2005 1655 1665 (Pubitemid 40594165)
43. D.L. Hay, G. Christopoulos, A. Christopoulos, and P.M. Sexton Determinants of 1-piperidinecarboxamide, N-[2-[[5-amino-l-[[4-(4-pyridinyl)-l- piperazinyl]carbonyl]pentyl]amino]-1-[(3,5-dibromo-4-hydroxyphenyl)methyl] -2-oxoethyl]-4-(1,4-dihydro-2-oxo-3(2 H)-quinazolinyl) (BIBN4096BS) affinity for calcitonin gene-related peptide and amylin receptors - the role of receptor activity modifying protein 1 Mol Pharmacol 70 2006 1984 1991 (Pubitemid 44771914)
44. D.L. Hay, A.C. Conner, S.G. Howitt, D.M. Smith, and D.R. Poyner The pharmacology of adrenomedullin receptors and their relationship to CGRP receptors J Mol Neurosci 22 2004 105 113 (Pubitemid 41359020)
45. D.L. Hay, S.G. Howitt, A.C. Conner, H. Doods, M. Schindler, and D.R. Poyner A comparison of the actions of BIBN4096BS and CGRP(8-37) on CGRP and adrenomedullin receptors expressed on SK-N-MC, L6, Col 29 and Rat 2 cells Br J Pharmacol 137 2002 80 86 (Pubitemid 34983466)
46. D.L. Hay, D.R. Poyner, and P.M. Sexton GPCR modulation by RAMPs Pharmacol Ther 109 2006 173 197 (Pubitemid 41740820)
47. D.L. Hay, C.S. Walker, and D.R. Poyner Adrenomedullin and calcitonin gene-related peptide receptors in endocrine-related cancers: opportunities and challenges Endocr Relat Cancer 18 2011 C1 14
48. S. Hilairet, C. Belanger, J. Bertrand, A. Laperriere, S.M. Foord, and M. Bouvier Agonist-promoted internalization of a ternary complex between calcitonin receptor-like receptor, receptor activity-modifying protein 1 (RAMP1), and beta-arrestin J Biol Chem 276 2001 42182 42190
49. S. Hilairet, S.M. Foord, F.H. Marshall, and M. Bouvier Protein-protein interaction and not glycosylation determines the binding selectivity of heterodimers between the calcitonin receptor-like receptor and the receptor activity-modifying proteins J Biol Chem 276 2001 29575 29581
50. K. Hiragushi, J. Wada, J. Eguchi, T. Matsuoka, A. Yasuhara, and I. Hashimoto The role of adrenomedullin and receptors in glomerular hyperfiltration in streptozotocin-induced diabetic rats Kidney Int 65 2004 540 550 (Pubitemid 38130648)
51. T. Hirose, K. Totsune, N. Mori, T. Mori, R. Morimoto, and H. Metoki Expression of adrenomedullin 2/intermedin, a possible reno-protective peptide, is decreased in the kidneys of rats with hypertension or renal failure Am J Physiol Renal Physiol 299 2010 F128 F134
52. T. Hirose, K. Totsune, N. Mori, R. Morimoto, M. Hashimoto, and Y. Nakashige Increased expression of adrenomedullin 2/intermedin in rat hearts with congestive heart failure Eur J Heart Fail 10 2008 840 849
53. T.W. Ho, M.D. Ferrari, D.W. Dodick, V. Galet, J. Kost, and X. Fan Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial Lancet 372 2008 2115 2123
54. M. Honda, S. Nakagawa, K. Hayashi, N. Kitagawa, K. Tsutsumi, and I. Nagata Adrenomedullin improves the blood-brain barrier function through the expression of claudin-5 Cell Mol Neurobiol 26 2006 109 118 (Pubitemid 43881818)
55. K. Husmann, W. Born, J.A. Fischer, and R. Muff Three receptor-activity- modifying proteins define calcitonin gene-related peptide or adrenomedullin selectivity of the mouse calcitonin-like receptor in COS-7 cells Biochem Pharmacol 66 2003 2107 2115 (Pubitemid 37377856)
56. K. Husmann, P.M. Sexton, J.A. Fischer, and W. Born Mouse receptor-activity-modifying proteins 1, -2 and -3: amino acid sequence, expression and function Mol Cell Endocrinol 162 2000 35 43 (Pubitemid 30347446)
57. Y. Ichikawa-Shindo, T. Sakurai, A. Kamiyoshi, H. Kawate, N. Iinuma, and T. Yoshizawa The GPCR modulator protein RAMP2 is essential for angiogenesis and vascular integrity J Clin Invest 118 2008 29 39
58. S. Iimuro, T. Shindo, N. Moriyama, T. Amaki, P. Niu, and N. Takeda Angiogenic effects of adrenomedullin in ischemia and tumor growth Circ Res 95 2004 415 423 (Pubitemid 39100460)
59. T. Ishimitsu, H. Ono, J. Minami, and H. Matsuoka Pathophysiologic and therapeutic implications of adrenomedullin in cardiovascular disorders Pharmacol Ther 111 2006 909 927 (Pubitemid 44118439)
60. Y.X. Jia, J.H. Yang, C.S. Pan, B. Geng, J. Zhang, and Y. Xiao Intermedin1-53 protects the heart against isoproterenol-induced ischemic injury in rats Eur J Pharmacol 549 2006 117 123 (Pubitemid 44441261)
61. D. Jin, K. Harada, S. Ohnishi, K. Yamahara, K. Kangawa, and N. Nagaya Adrenomedullin induces lymphangiogenesis and ameliorates secondary lymphoedema Cardiovasc Res 80 2008 339 345
62. H. Kamoi, H. Kanazawa, K. Hirata, N. Kurihara, Y. Yano, and S. Otani Adrenomedullin inhibits the secretion of cytokine-induced neutrophil chemoattractant, a member of the interleukin-8 family, from rat alveolar macrophages Biochem Biophys Res Commun 211 1995 1031 1035
63. Y. Kataoka, S. Miyazaki, S. Yasuda, N. Nagaya, T. Noguchi, and N. Yamada The first clinical pilot study of intravenous adrenomedullin administration in patients with acute myocardial infarction J Cardiovasc Pharmacology 56 2010 413 419
64. J. Kato, T. Tsuruda, T. Kita, K. Kitamura, and T. Eto Adrenomedullin: a protective factor for blood vessels Arterioscler Thromb Vasc Biol 25 2005 2480 2487 (Pubitemid 43732267)
65. B. Kis, C.S. Abraham, M.A. Deli, H. Kobayashi, M. Niwa, and H. Yamashita Adrenomedullin, an autocrine mediator of blood-brain barrier function Hypertens Res: Official J Jpn Soc Hypertens 26 Suppl. 2003 S61 S70
66. B. Kis, H. Kaiya, R. Nishi, M.A. Deli, C.S. Abraham, and T. Yanagita Cerebral endothelial cells are a major source of adrenomedullin J Neuroendocrinol 14 2002 283 293 (Pubitemid 34285297)
67. K. Kitamura, K. Kangawa, and T. Eto Adrenomedullin and PAMP: discovery, structures, and cardiovascular functions Microsc Res Tech 57 2002 3 13 (Pubitemid 34242539)
68. K. Kitamura, K. Kangawa, M. Kawamoto, Y. Ichiki, S. Nakamura, and H. Matsuo Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma Biochem Biophys Res Commun 192 1993 553 560 (Pubitemid 23227359)
69. D. Koller, W. Born, K. Leuthauser, B. Fluhmann, R.A. McKinney, and J.A. Fischer The extreme N-terminus of the calcitonin-like receptor contributes to the selective interaction with adrenomedullin or calcitonin gene-related peptide FEBS Lett 531 2002 464 468 (Pubitemid 35336070)
70. D. Koller, L.M. Ittner, R. Muff, K. Husmann, J.A. Fischer, and W. Born Selective inactivation of adrenomedullin over calcitonin gene-related peptide receptor function by the deletion of amino acids 14-20 of the mouse calcitonin-like receptor J Biol Chem 279 2004 20387 20391 (Pubitemid 38623485)
71. S. Kusano, M. Kukimoto-Niino, R. Akasaka, M. Toyama, T. Terada, and M. Shirouzu Crystal structure of the human receptor activity-modifying protein 1 extracellular domain Protein Sci 17 2008 1907 1914
72. K. Kuwasako, Y.N. Cao, C.P. Chu, S. Iwatsubo, T. Eto, and K. Kitamura Functions of the cytoplasmic tails of the human receptor activity-modifying protein components of calcitonin gene-related peptide and adrenomedullin receptors J Biol Chem 281 2006 7205 7213 (Pubitemid 43847487)
73. K. Kuwasako, Y.N. Cao, Y. Nagoshi, K. Kitamura, and T. Eto Adrenomedullin receptors: pharmacological features and possible pathophysiological roles Peptides 25 2004 2003 2012 (Pubitemid 39389197)
74. K. Kuwasako, Y.N. Cao, Y. Nagoshi, T. Tsuruda, K. Kitamura, and T. Eto Characterization of the human calcitonin gene-related peptide receptor subtypes associated with receptor activity-modifying proteins Mol Pharmacol 65 2004 207 213 (Pubitemid 38113901)
75. K. Kuwasako, K. Kitamura, K. Ito, T. Uemura, Y. Yanagita, and J. Kato The seven amino acids of human RAMP2 (86) and RAMP3 (59) are critical for agonist binding to human adrenomedullin receptors J Biol Chem 276 2001 49459 49465
76. K. Kuwasako, K. Kitamura, S. Nagata, T. Hikosaka, and J. Kato Function of the cytoplasmic tail of human calcitonin receptor-like receptor in complex with receptor activity-modifying protein 2 Biochem Biophys Res Commun 392 2010 380 385
77. K. Kuwasako, K. Kitamura, S. Nagata, and J. Kato Functions of the extracellular histidine residues of receptor activity-modifying proteins vary within adrenomedullin receptors Biochem Biophys Res Commun 377 2008 109 113
78. K. Kuwasako, K. Kitamura, Y. Nagoshi, Y.N. Cao, and T. Eto Identification of the human receptor activity-modifying protein 1 domains responsible for agonist binding specificity J Biol Chem 278 2003 22623 22630 (Pubitemid 36830320)
79. K. Kuwasako, K. Kitamura, T. Uemura, Y. Nagoshi, J. Kato, and T. Eto The function of extracellular cysteines in the human adrenomedullin receptor Hypertens Res 26 Suppl. 2003 S25 31
80. K. Kuwasako, Y. Shimekake, M. Masuda, K. Nakahara, T. Yoshida, and M. Kitaura Visualization of the calcitonin receptor-like receptor and its receptor activity-modifying proteins during internalization and recycling J Biol Chem 275 2000 29602 29609 (Pubitemid 32043838)
81. Y. Li, C. Jiang, X. Wang, Y. Zhang, S. Shibahara, and K. Takahashi Adrenomedullin is a novel adipokine: adrenomedullin in adipocytes and adipose tissues Peptides 28 2007 1129 1143 (Pubitemid 46654447)
82. L. Liang, C.W. Tam, G. Pozsgai, R. Siow, N. Clark, and J. Keeble Protection of angiotensin II-induced vascular hypertrophy in vascular smooth muscle-targeted receptor activity-modifying protein 2 transgenic mice Hypertension 54 2009 1254 1261
83. E. Matsui, K. Kitamura, M. Yoshida, J. Kato, Y. Asada, and A. Sumiyoshi Biosynthesis and secretion of adrenomedullin and proadrenomedullin N-terminal 20 peptide in a rat model of endotoxin shock Hypertens Res 24 2001 543 549 (Pubitemid 33048921)
84. L.M. McLatchie, N.J. Fraser, M.J. Main, A. Wise, J. Brown, and N. Thompson RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor Nature 393 1998 333 339 (Pubitemid 28269699)
85. J.J. Miret, L. Rakhilina, L. Silverman, and B. Oehlen Functional expression of heteromeric calcitonin gene-related peptide and adrenomedullin receptors in yeast J Biol Chem 277 2002 6881 6887 (Pubitemid 34953072)
86. R. Muff, W. Born, and J.A. Fischer Adrenomedullin selectivity of calcitonin-like receptor/receptor activity modifying proteins Hypertens Res 26 Suppl. 2003 S3 8
87. T. Nagae, M. Mukoyama, A. Sugawara, K. Mori, K. Yahata, and M. Kasahara Rat receptor-activity-modifying proteins (RAMPs) for adrenomedullin/CGRP receptor: cloning and upregulation in obstructive nephropathy Biochem Biophys Res Commun 270 2000 89 93 (Pubitemid 30440397)
88. N. Nagaya, H. Mori, S. Murakami, K. Kangawa, and S. Kitamura Adrenomedullin: angiogenesis and gene therapy Am J Physiol Regul, Integr Comp Physiol 288 2005 R1432 R1437
89. Y. Nagoshi, K. Kuwasako, K. Ito, T. Uemura, J. Kato, and K. Kitamura The calcitonin receptor-like receptor/receptor activity-modifying protein 1 heterodimer can function as a calcitonin gene-related peptide-(8-37)-sensitive adrenomedullin receptor Eur J Pharmacol 450 2002 237 243 (Pubitemid 35246065)
90. R. Nakamura, J. Kato, K. Kitamura, H. Onitsuka, T. Imamura, and Y. Cao Adrenomedullin administration immediately after myocardial infarction ameliorates progression of heart failure in rats Circulation 110 2004 426 431 (Pubitemid 38993852)
91. L.L. Nikitenko, N. Blucher, S.B. Fox, R. Bicknell, D.M. Smith, and M.C. Rees Adrenomedullin and CGRP interact with endogenous calcitonin-receptor-like receptor in endothelial cells and induce its desensitisation by different mechanisms J Cell Sci 119 2006 910 922
92. L.L. Nikitenko, S.B. Fox, S. Kehoe, M.C. Rees, and R. Bicknell Adrenomedullin and tumour angiogenesis Br J Cancer 94 2006 1 7 (Pubitemid 43088532)
93. T. Nishikimi Adrenomedullin in the kidney-renal physiological and pathophysiological roles Curr Med Chem 14 2007 1689 1699 (Pubitemid 47010156)
94. T. Nishikimi, T. Horio, F. Yoshihara, N. Nagaya, H. Matsuo, and K. Kangawa Effect of adrenomedullin on cAMP and cGMP levels in rat cardiac myocytes and nonmyocytes Eur J Pharmacol 353 1998 337 344 (Pubitemid 28352281)
95. T. Nishikimi, T. Karasawa, C. Inaba, K. Ishimura, K. Tadokoro, and S. Koshikawa Effects of long-term intravenous administration of adrenomedullin (AM) plus hANP therapy in acute decompensated heart failure: a pilot study Circulation J: Official J Jpn Circulation Soc 73 2009 892 898
96. T. Nishikimi, K. Tadokoro, Y. Mori, X. Wang, K. Akimoto, and F. Yoshihara Ventricular adrenomedullin system in the transition from LVH to heart failure in rats Hypertension 41 2003 512 518 (Pubitemid 36314625)
97. K. Nishio, Y. Akai, Y. Murao, N. Doi, S. Ueda, and H. Tabuse Increased plasma concentrations of adrenomedullin correlate with relaxation of vascular tone in patients with septic shock Crit Care Med 25 1997 953 957 (Pubitemid 27264238)
98. E. Oie, M.S. Ahmed, T. Ueland, L.I. Sikkeland, C.P. Dahl, and E.M. Hagelin Adrenomedullin is increased in alveolar macrophages and released from the lungs into the circulation in severe heart failure Basic Res Cardiol 105 2010 89 98
99. J. Olesen, H.C. Diener, I.W. Husstedt, P.J. Goadsby, D. Hall, and U. Meier Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine N Engl J Med 350 2004 1104 1110 (Pubitemid 38298990)
100. K.R. Oliver, S.A. Kane, C.A. Salvatore, J.J. Mallee, A.M. Kinsey, and K.S. Koblan Cloning, characterization and central nervous system distribution of receptor activity modifying proteins in the rat Eur J Neurosci 14 2001 618 628
101. H. Onitsuka, T. Imamura, K. Ito, K. Kuwasako, H. Yamakawa, and S. Hirano Differential gene expression of adrenomedullin receptors in pressure and volumeoverloaded heart role of angiotensin II Peptides 25 2004 1107 1114 (Pubitemid 38881650)
102. Y. Ono, I. Okano, M. Kojima, K. Okada, and K. Kangawa Decreased gene expression of adrenomedullin receptor in mouse lungs during sepsis Biochem Biophys Res Commun 271 2000 197 202 (Pubitemid 30444877)
103. H. Oya, N. Nagaya, S. Furuichi, T. Nishikimi, K. Ueno, and N. Nakanishi Comparison of intravenous adrenomedullin with atrial natriuretic peptide in patients with congestive heart failure Am J Cardiol 86 2000 94 98 (Pubitemid 30365153)
104. S. Pan Ch, W. Jiang, Y. Wu Sh, J. Zhao, Y.Z. Pang, and S. Tang Ch Potentiated response to adrenomedullin in myocardia and aortas in spontaneously hypertensive rat Basic Res Cardiol 101 2006 193 203
105. C.S. Pan, W. Jiang, G.Z. Zhong, J. Zhao, Y.Z. Pang, and C.S. Tang Hypertension induced by nitric oxide synthase inhibitor increases responsiveness of ventricular myocardium and aorta of rat tissue to adrenomedullin stimulation in vitro Life Sci 78 2005 398 405 (Pubitemid 41597549)
106. C.S. Pan, Y.F. Qi, S.Y. Wu, W. Jiang, G.Z. Li, and C.S. Tang The role of adrenomedullin and its receptor system in cardiovascular calcification of rat induced by Vitamin D(3) plus nicotine Peptides 25 2004 601 608 (Pubitemid 38681059)
107. N. Parameswaran, and W.S. Spielman RAMPs: the past, present and future Trends Biochem Sci 31 2006 631 638 (Pubitemid 44635265)
108. D.R. Poyner, P.M. Sexton, I. Marshall, D.M. Smith, R. Quirion, and W. Born International Union of Pharmacology, XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors Pharmacol Rev 54 2002 233 246 (Pubitemid 34575714)
109. T. Qi, G. Christopoulos, R.J. Bailey, A. Christopoulos, P.M. Sexton, and D.L. Hay Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function Mol Pharmacol 74 2008 1059 1071
110. T. Qi, and D.L. Hay Structure-function relationships of the N-terminus of receptor activity-modifying proteins Br J Pharmacol 159 2010 1059 1068
111. T. Qi, K. Ly, D.R. Poyner, G. Christopoulos, P.M. Sexton, and D.L. Hay Structure-function analysis of amino acid 74 of human RAMP1 and RAMP3 and its role in peptide interactions with adrenomedullin and calcitonin gene-related peptide receptors Peptides 2011
112. Y.F. Qi, Y.R. Shi, D.F. Bu, Y.Z. Pang, and C.S. Tang Changes of adrenomedullin and receptor activity modifying protein 2 (RAMP2) in myocardium and aorta in rats with isoproterenol-induced myocardial ischemia Peptides 24 2003 463 468 (Pubitemid 36561220)
113. S.D. Robinson, J.F. Aitken, R.J. Bailey, D.R. Poyner, and D.L. Hay Novel peptide antagonists of adrenomedullin and calcitonin gene-related peptide receptors: identification, pharmacological characterization, and interactions with position 74 in receptor activity-modifying protein 1/3 J Pharmacol Exp Ther 331 2009 513 521
114. J. Roh, C.L. Chang, A. Bhalla, C. Klein, and S.Y. Hsu Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes J Biol Chem 279 2004 7264 7274 (Pubitemid 38248876)
115. P.M. Sexton, A. Albiston, M. Morfis, and N. Tilakaratne Receptor activity modifying proteins Cell Signal 13 2001 73 83 (Pubitemid 32222976)
116. P.M. Sexton, D.R. Poyner, J. Simms, A. Christopoulos, and D.L. Hay Modulating receptor function through RAMPs: can they represent drug targets in themselves? Drug Discov Today 14 2009 413 419
117. T. Shimosawa, and T. Fujita Adrenomedullin as a potent antioxidative and antiatherosclerotic substance Drug News Perspect 18 2005 185 189 (Pubitemid 40704840)
118. T. Shindo, Y. Kurihara, H. Nishimatsu, N. Moriyama, M. Kakoki, and Y. Wang Vascular abnormalities and elevated blood pressure in mice lacking adrenomedullin gene Circulation 104 2001 1964 1971 (Pubitemid 32983242)
119. J. Simms, D.L. Hay, R.J. Bailey, G. Konycheva, G. Bailey, and M. Wheatley Structure-function analysis of RAMP1 by alanine mutagenesis Biochemistry 48 2009 198 205
120. J. Simms, D.L. Hay, M. Wheatley, and D.R. Poyner Characterization of the structure of RAMP1 by mutagenesis and molecular modeling Biophys J 91 2006 662 669
121. F.Y. Siu, and R.C. Stevens RAMP-ing up class-B GPCR ECD structural coverage Structure 18 2010 1067 1068
122. R.S. Smith Jr., L. Gao, G. Bledsoe, L. Chao, and J. Chao Intermedin is a new angiogenic growth factor Am J Physiol Heart Circulatory Physiol 297 2009 H1040 H1047
123. P.H. Steenbergh, J.W. Hoppener, J. Zandberg, C.J. Lips, and H.S. Jansz A second human calcitonin/CGRP gene FEBS Lett 183 1985 403 407 (Pubitemid 15042760)
124. S. Steiner, W. Born, J.A. Fischer, and R. Muff The function of conserved cysteine residues in the extracellular domain of human receptor-activity- modifying protein FEBS Lett 555 2003 285 290 (Pubitemid 37486042)
125. S. Steiner, R. Muff, R. Gujer, J.A. Fischer, and W. Born The transmembrane domain of receptor-activity-modifying protein 1 is essential for the functional expression of a calcitonin gene-related peptide receptor Biochemistry 41 2002 11398 11404
126. Y. Tachi, D. Fukui, Y. Wada, M. Koshikawa, S. Shimodaira, and U. Ikeda Changes in angiogenesis-related factors in serum following autologous bone marrow cell implantation for severe limb ischemia Expert Opin Biol Therapy 8 2008 705 712 (Pubitemid 351860199)
127. K. Tadokoro, T. Nishikimi, Y. Mori, X. Wang, K. Akimoto, and H. Matsuoka Altered gene expression of adrenomedullin and its receptor system and molecular forms of tissue adrenomedullin in left ventricular hypertrophy induced by malignant hypertension Regul Pept 112 2003 71 78 (Pubitemid 36351605)
128. K. Takahashi, T. Hirose, N. Mori, R. Morimoto, M. Kohzuki, and Y. Imai The renin-angiotensin system, adrenomedullins and urotensin II in the kidney: possible renoprotection via the kidney peptide systems Peptides 30 2009 1575 1585
129. K. Takahashi, R. Morimoto, T. Hirose, F. Satoh, and K. Totsune Adrenomedullin 2/intermedin in the hypothalamo-pituitary-adrenal axis J Mol Neurosci 43 2011 182 192
130. Y. Takei, S. Hyodo, T. Katafuchi, and N. Minamino Novel fish-derived adrenomedullin in mammals: structure and possible function Peptides 25 2004 1643 1656 (Pubitemid 39346206)
131. Y. Takei, K. Inoue, M. Ogoshi, T. Kawahara, H. Bannai, and S. Miyano Identification of novel adrenomedullin in mammals: a potent cardiovascular and renal regulator FEBS Lett 556 2004 53 58 (Pubitemid 38058554)
132. C.W. Tam, K. Husmann, N.C. Clark, J.E. Clark, Z. Lazar, and L.M. Ittner Enhanced vascular responses to adrenomedullin in mice overexpressing receptor-activity-modifying protein 2 Circ Res 98 2006 262 270
133. M.M. Taylor, S.L. Bagley, and W.K. Samson Intermedin/Adrenomedullin-2 inhibits growth hormone release from cultured, primary anterior pituitary cells Endocrinology 147 2006 859 864 (Pubitemid 43113003)
134. E. ter Haar, C.M. Koth, N. Abdul-Manan, L. Swenson, J.T. Coll, and J.A. Lippke Crystal structure of the ectodomain complex of the CGRP receptor, a class-B GPCR, reveals the site of drug antagonism Structure 18 2010 1083 1093
135. N. Tilakaratne, G. Christopoulos, E.T. Zumpe, S.M. Foord, and P.M. Sexton Amylin receptor phenotypes derived from human calcitonin receptor/RAMP coexpression exhibit pharmacological differences dependent on receptor isoform
136. Y. Tomoda, Y. Isumi, T. Katafuchi, and N. Minamino Regulation of adrenomedullin secretion from cultured cells Peptides 22 2001 1783 1794 (Pubitemid 34062795)
137. Y. Tomoda, K. Kikumoto, Y. Isumi, T. Katafuchi, A. Tanaka, and K. Kangawa Cardiac fibroblasts are major production and target cells of adrenomedullin in the heart in vitro Cardiovasc Res 49 2001 721 730 (Pubitemid 32178375)
138. K. Totsune, K. Takahashi, H.S. Mackenzie, Z. Arihara, F. Satoh, and M. Sone Adrenomedullin and its receptor complexes in remnant kidneys of rats with renal mass ablation: decreased expression of calcitonin receptor-like receptor and receptor-activity modifying protein-3 Peptides 22 2001 1933 1937 (Pubitemid 34062815)
139. T. Tsuruda, J. Kato, K. Kitamura, K. Kuwasako, T. Imamura, and Y. Koiwaya Adrenomedullin: a possible autocrine or paracrine inhibitor of hypertrophy of cardiomyocytes Hypertension 31 1998 505 510
140. M. Udawela, G. Christopoulos, M. Morfis, A. Christopoulos, S. Ye, and N. Tilakaratne A critical role for the short intracellular C terminus in receptor activity-modifying protein function Mol Pharmacol 70 2006 1750 1760
141. S.J. Wimalawansa Amylin, calcitonin gene-related peptide, calcitonin, and adrenomedullin: a peptide superfamily Crit Rev Neurobiol 11 1997 167 239 (Pubitemid 27453169)
142. F. Wunder, A. Rebmann, A. Geerts, and B. Kalthof Pharmacological and kinetic characterization of adrenomedullin 1 and calcitonin gene-related peptide 1 receptor reporter cell lines Mol Pharmacol 73 2008 1235 1243 (Pubitemid 351439205)
143. T. Yamaguchi, K. Baba, Y. Doi, and K. Yano Effect of adrenomedullin on aldosterone secretion by dispersed rat adrenal zona glomerulosa cells Life Sci 56 1995 379 387 (Pubitemid 124015456)
144. T. Yamaguchi, K. Baba, Y. Doi, K. Yano, K. Kitamura, and T. Eto Inhibition of aldosterone production by adrenomedullin, a hypotensive peptide, in the rat Hypertension 28 1996 308 314 (Pubitemid 26322807)
145. Y. Zhao, D. Bell, L.R. Smith, L. Zhao, A.B. Devine, and E.M. McHenry Differential expression of components of the cardiomyocyte adrenomedullin/ intermedin receptor system following blood pressure reduction in nitric oxide-deficient hypertension J Pharmacol Exp Ther 316 2006 1269 1281 (Pubitemid 43345303)